In 2005, Tailing Pharmaceutical (Group) Co., Ltd. achieved sales of RMB 2 billion. The sales network of pharmaceutical products covers 55 large and medium-sized cities and more than 500 core hospitals in China, and has established a solid business relationship with more than 200 distributors. Hainan Tailing Biological Products Co., Ltd., a subsidiary of the Group, serves as GlaxoSmithKline & reg；; (GSK) The distributor and distribution network of vaccine products in Chinese mainland directly covers more than 430 centers for disease control in China. A standardized and perfect sales network can ensure that the products we operate can meet the needs of the terminal quickly and widely.
Tailing Pharmaceutical (Group) Co., Ltd. has established long-term good cooperative partnership with many world-leading multinational pharmaceutical enterprises and well-known domestic enterprises by virtue of the corporate philosophy of honest service, unity and forge ahead, pioneering and innovative, and dedication to society. Major international partners include GlaxoSmithKline &; Reg(GSK), Pfizer &; Reg Pfizer (Pfizer), Roche & Novartis Pharmaceutical Company; (Novartis), Braun &; Reg(B | Braun), etc. With pioneering spirit and profound academic background, the research team actively communicates and cooperates with the original R&D pharmaceutical factory and professional research institutions at home and abroad, obtains the latest research results and introduces them into the China market, so as to ensure that new products are put into the China market through Tailing's marketing channels every year. Tailing people will adhere to the innovative spirit of the times, create a competitive new business model in the field of medicine and health in China, and become a new force to promote the development of medicine and health industry in China.